Because the transactivation domain of E2F4 is normally inhibited upon RB family binding, we speculate that the pro-proliferative role of E2F4 may be restricted to cell types where the RB family proteins are inactive, as in rapidly cycling progenitor cells and cancer cells. Here, E2F4 is linked to cancer.